Literature DB >> 28228594

The B Cell Response to Foot-and-Mouth Disease Virus in Cattle following Sequential Vaccination with Multiple Serotypes.

Clare F J Grant1, B Veronica Carr1, Abhay Kotecha2, Erwin van den Born3, David I Stuart2, John A Hammond1, Bryan Charleston4.   

Abstract

Foot-and-mouth disease virus (FMDV) is a highly contagious viral disease. Antibodies are pivotal in providing protection against FMDV infection. Serological protection against one FMDV serotype does not confer interserotype protection. However, some historical data have shown that interserotype protection can be induced following sequential FMDV challenge with multiple FMDV serotypes. In this study, we have investigated the kinetics of the FMDV-specific antibody-secreting cell (ASC) response following homologous and heterologous inactivated FMDV vaccination regimes. We have demonstrated that the kinetics of the B cell response are similar for all four FMDV serotypes tested following a homologous FMDV vaccination regime. When a heterologous vaccination regime was used with the sequential inoculation of three different inactivated FMDV serotypes (O, A, and Asia1 serotypes) a B cell response to FMDV SAT1 and serotype C was induced. The studies also revealed that the local lymphoid tissue had detectable FMDV-specific ASCs in the absence of circulating FMDV-specific ASCs, indicating the presence of short-lived ASCs, a hallmark of a T-independent 2 (TI-2) antigenic response to inactivated FMDV capsid.IMPORTANCE We have demonstrated the development of intraserotype response following a sequential vaccination regime of four different FMDV serotypes. We have found indication of short-lived ASCs in the local lymphoid tissue, further evidence of a TI-2 response to FMDV.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  B cell; FMDV; T-independent; viral immunology

Mesh:

Substances:

Year:  2017        PMID: 28228594      PMCID: PMC5391442          DOI: 10.1128/JVI.02157-16

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  14 in total

1.  Maintenance of serological memory by polyclonal activation of human memory B cells.

Authors:  Nadia L Bernasconi; Elisabetta Traggiai; Antonio Lanzavecchia
Journal:  Science       Date:  2002-12-13       Impact factor: 47.728

2.  High potency vaccines induce protection against heterologous challenge with foot-and-mouth disease virus.

Authors:  K E Brehm; N Kumar; H-H Thulke; B Haas
Journal:  Vaccine       Date:  2008-02-12       Impact factor: 3.641

3.  A new enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies against foot-and-mouth disease virus. II. Application.

Authors:  C Hamblin; I T Barnett; J R Crowther
Journal:  J Immunol Methods       Date:  1986-10-23       Impact factor: 2.303

4.  CRM197-conjugated serogroup C meningococcal capsular polysaccharide, but not the native polysaccharide, induces persistent antigen-specific memory B cells.

Authors:  Dominic F Kelly; Mathew D Snape; Elizabeth A Clutterbuck; Elizabeth A Cutterbuck; Sarah Green; Claire Snowden; Linda Diggle; Ly-mee Yu; Astrid Borkowski; E Richard Moxon; Andrew J Pollard
Journal:  Blood       Date:  2006-05-04       Impact factor: 22.113

Review 5.  Natural and vaccine-induced immunity to foot and mouth disease: the prospects for improved vaccines.

Authors:  T R Doel
Journal:  Rev Sci Tech       Date:  1996-09       Impact factor: 1.181

6.  Assessment of T-dependent and T-independent immune responses in cattle using a B cell ELISPOT assay.

Authors:  Clare Fj Grant; Eric A Lefevre; B Veronica Carr; Helen Prentice; Simon Gubbins; Andrew J Pollard; Catherine Charreyre; Bryan Charleston
Journal:  Vet Res       Date:  2012-10-10       Impact factor: 3.683

7.  The relationship between antigenic structure and the requirement for thymus-derived cells in the immune response.

Authors:  M Feldmann; A Easten
Journal:  J Exp Med       Date:  1971-07-01       Impact factor: 14.307

8.  Manipulating the selection forces during affinity maturation to generate cross-reactive HIV antibodies.

Authors:  Shenshen Wang; Jordi Mata-Fink; Barry Kriegsman; Melissa Hanson; Darrell J Irvine; Herman N Eisen; Dennis R Burton; K Dane Wittrup; Mehran Kardar; Arup K Chakraborty
Journal:  Cell       Date:  2015-02-05       Impact factor: 41.582

9.  Structure-based energetics of protein interfaces guides foot-and-mouth disease virus vaccine design.

Authors:  Abhay Kotecha; Julian Seago; Katherine Scott; Alison Burman; Silvia Loureiro; Jingshan Ren; Claudine Porta; Helen M Ginn; Terry Jackson; Eva Perez-Martin; C Alistair Siebert; Guntram Paul; Juha T Huiskonen; Ian M Jones; Robert M Esnouf; Elizabeth E Fry; Francois F Maree; Bryan Charleston; David I Stuart
Journal:  Nat Struct Mol Biol       Date:  2015-09-21       Impact factor: 15.369

10.  A quantitative assessment of primary and secondary immune responses in cattle using a B cell ELISPOT assay.

Authors:  Eric A Lefevre; B Veronica Carr; Helen Prentice; Bryan Charleston
Journal:  Vet Res       Date:  2008-10-03       Impact factor: 3.683

View more
  3 in total

1.  Development and Validation of a Competitive ELISA Based on Bovine Monoclonal Antibodies for the Detection of Neutralizing Antibodies against Foot-and-Mouth Disease Virus Serotype A.

Authors:  Yimei Cao; Kun Li; Xiangchuan Xing; Guoqiang Zhu; Yuanfang Fu; Huifang Bao; Xingwen Bai; Pu Sun; Pinghua Li; Jing Zhang; Xueqing Ma; Jian Wang; Zhixun Zhao; Dong Li; Zaixin Liu; Zengjun Lu
Journal:  J Clin Microbiol       Date:  2022-03-07       Impact factor: 11.677

Review 2.  Evolutionary and Structural Overview of Human Picornavirus Capsid Antibody Evasion.

Authors:  Javier Orlando Cifuente; Gonzalo Moratorio
Journal:  Front Cell Infect Microbiol       Date:  2019-08-20       Impact factor: 5.293

3.  Cross-Protection Induced by a A/MAY/97 Emergency Vaccine Against Intra-Serotype Heterologous Challenge with a Foot-and-Mouth Disease Virus from the A/ASIA/G-VII Lineage.

Authors:  Aldo Dekker; Beatriz Sanz-Bernardo; Nagendrakumar Balasubramanian Singanallur; Anna B Ludi; Jacquelyn Horsington; Phaedra L Eblé; Donald P King; Wilna Vosloo
Journal:  Vaccines (Basel)       Date:  2020-01-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.